These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 91197)

  • 1. Disopyramide--an effective treatment for lignocaine resistant ventricular dysrhythmias.
    Green AG
    Scott Med J; 1979 Jan; 24(1):21-4. PubMed ID: 91197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction.
    Rønnevik PK; Gundersen T; Abrahamsen AM
    Eur Heart J; 1987 Jan; 8(1):19-24. PubMed ID: 2880718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled study to determine the efficacy of oral disopyramide phosphate for the prophylaxis of ventricular dysrhythmias after acute myocardial infarction.
    Kumana CR; Rambihar VS; Tanser PH; Cairns JA; Gupta RN; Wildeman RA; Johnston M; Johnson AL; Gent M
    Br J Clin Pharmacol; 1982 Oct; 14(4):519-27. PubMed ID: 6753887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of disopyramide in resistant cardiac arrhythmias due to acute ischaemic heart disease.
    Sandler G
    J Int Med Res; 1977; 5(5):369-73. PubMed ID: 913864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disopyramide and lignocaine in the treatment of ventricular arrhythmia in patients with acute ischemic heart disease].
    Pedersen-Bjergaard O; Lindeneg O; Svendsen TL; Enk B; Fridberg M
    Ugeskr Laeger; 1986 May; 148(22):1349-51. PubMed ID: 3523916
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of intravenous disopyramide in acute cardiac arrhythmias.
    De Backer M; Stoupel E; Kahn RJ
    Eur J Clin Pharmacol; 1981 Jan; 19(1):11-8. PubMed ID: 6161824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial.
    Trimarco B; Volpe M; Ricciardelli B; Sacca' L; De Luca N; Rengo F; Condorelli M
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):251-9. PubMed ID: 7013721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the preventive method of lowered ventricular fibrillation threshold during experimental acute myocardial infarctions. A comparison between disopyramide phosphate and lidocaine.
    Hori Y; Okamoto R; Hatani M; Imai N; Toh H; Takano S; Nadai T; Fukuzaki H
    Jpn Heart J; 1981 Sep; 22(5):801-13. PubMed ID: 7321204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
    Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide.
    Allen-Narker RA; Roberts CJ; Marshall AJ; Jordan SC; Barritt DW; Goodfellow RM
    Br J Clin Pharmacol; 1984 Nov; 18(5):725-32. PubMed ID: 6439233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiarrhythmic effect of intravenous disopyramide in an open study.
    Tonkin AM; Heddle WF; Bett JH; Kemp RJ; Donnelly GL; Nelson GI; Manolas E; Sloman JG
    Aust N Z J Med; 1982 Aug; 12(4):271-5. PubMed ID: 6958238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Data on disopyridamide therapy of some arrhythmias].
    Perroni GB; Briguglio FS; Oddo A; Trovato G
    Minerva Med; 1977 Jun; 68(32):2271-4. PubMed ID: 69277
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of disturbances of cardiac rhythm using intravenous disopyramide].
    Lisin N; Andriange M; Vandenbosch R; Carlier J
    Rev Med Liege; 1974 May; 29(9):256-64. PubMed ID: 4134825
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy of disopyramide and mexiletine per os in the chronic treatment of ventricular arrhythmias sensitive to lidocaine].
    Ricciardelli B; Volpe M; De Luca N; D'Ascia C; Bonaduce D; Trimarco B; Rengo F; Condorelli M
    Boll Soc Ital Cardiol; 1981; 26(2):139-44. PubMed ID: 7337769
    [No Abstract]   [Full Text] [Related]  

  • 15. [Disopyramide in the prevention of arrhythmia following myocardial infarction and resistant arrhythmia].
    Dallocchio M; Daubeze J; Clementy J; Poisot D; Bricaud H; Broustet P
    Therapie; 1974; 29(1):119-29. PubMed ID: 4848509
    [No Abstract]   [Full Text] [Related]  

  • 16. Disopyramide: a new agent for effective therapy of ventricular dysrhythmias.
    Mason DT
    Drugs; 1978 May; 15(5):329-30. PubMed ID: 657990
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of ventricular arrhythmias with intravenous disopyramide and lidocaine: efficacy comparison in a randomized trial.
    Sbarbaro JA; Rawling DA; Fozzard HA
    Am J Cardiol; 1979 Sep; 44(3):513-20. PubMed ID: 474432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disopyramide in the treatment and prevention of arrhythmias following myocardial infarction.
    Zainal N; Jennings G; Jones B; Model D; Turner P; Besterman EM; Kidner PH
    J Int Med Res; 1976; 4(1 Suppl):71-3. PubMed ID: 799982
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of disopyramide phosphate on ventricular arrhythmias in experimental myocardial infarction.
    Kus T; Sasyniuk BI
    J Pharmacol Exp Ther; 1976 Mar; 196(3):665-75. PubMed ID: 1263118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards.
    Zainal N; Carmichael DJ; Griffiths JW; Besterman EM; Kidner PH; Gillham AD; Summers GD
    Lancet; 1977 Oct; 2(8044):887-9. PubMed ID: 72237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.